Normal Th1 Development Following Long-Term Therapeutic Blockade of CD154-CD40 in Experimental Autoimmune Encephalomyelitis

Journal of Clinical Investigation - United States
doi 10.1172/jci14374
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Therapeutic Potential of Agmatine in the Experimental Autoimmune Encephalomyelitis

Vojnosanitetski Pregled
MedicinePharmacology
2019English

Notch Ligand Delta-Like 4 Blockade Alleviates Experimental Autoimmune Encephalomyelitis by Promoting Regulatory T Cell Development

Journal of Immunology
AllergyImmunology
2011English

Absence of Notch1 in Murine Myeloid Cells Attenuates the Development of Experimental Autoimmune Encephalomyelitis by Affecting Th1 and Th17 Priming

European Journal of Immunology
AllergyImmunology
2017English

Tumor Necrosis Factor-Α Blockade Treatment Decreased CD154 (CD40-ligand) Expression in Rheumatoid Arthritis

PLoS ONE
Multidisciplinary
2017English

Alpinia Oxyphylla Fruit Extract Ameliorates Experimental Autoimmune Encephalomyelitis Through the Regulation of Th1/Th17 Cells

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2019English

Mechanical Hypernociception in Experimental Autoimmune Encephalomyelitis

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2009English

Engineered Stem Cell-Derived Microglia as Therapeutic Vehicle for Experimental Autoimmune Encephalomyelitis

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2013English

Higher Susceptibility to Experimental Autoimmune Encephalomyelitis in Muc1-Deficient Mice Is Associated With Increased Th1/Th17 Responses

Brain, Behavior, and Immunity
EndocrineImmunologyBehavioral NeuroscienceAutonomic Systems
2013English

Prophylactic Versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering From Experimental Autoimmune Encephalomyelitis

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy